1. Home
  2. OLLI vs RYTM Comparison

OLLI vs RYTM Comparison

Compare OLLI & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLLI
  • RYTM
  • Stock Information
  • Founded
  • OLLI 1982
  • RYTM 2008
  • Country
  • OLLI United States
  • RYTM United States
  • Employees
  • OLLI N/A
  • RYTM N/A
  • Industry
  • OLLI Department/Specialty Retail Stores
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLLI Consumer Discretionary
  • RYTM Health Care
  • Exchange
  • OLLI Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • OLLI 7.6B
  • RYTM 6.4B
  • IPO Year
  • OLLI 2015
  • RYTM 2017
  • Fundamental
  • Price
  • OLLI $124.86
  • RYTM $108.45
  • Analyst Decision
  • OLLI Buy
  • RYTM Strong Buy
  • Analyst Count
  • OLLI 14
  • RYTM 13
  • Target Price
  • OLLI $143.43
  • RYTM $118.46
  • AVG Volume (30 Days)
  • OLLI 864.2K
  • RYTM 749.6K
  • Earning Date
  • OLLI 12-09-2025
  • RYTM 11-04-2025
  • Dividend Yield
  • OLLI N/A
  • RYTM N/A
  • EPS Growth
  • OLLI 5.15
  • RYTM N/A
  • EPS
  • OLLI 3.45
  • RYTM N/A
  • Revenue
  • OLLI $2,440,835,000.00
  • RYTM $174,334,000.00
  • Revenue This Year
  • OLLI $18.72
  • RYTM $46.10
  • Revenue Next Year
  • OLLI $12.79
  • RYTM $63.02
  • P/E Ratio
  • OLLI $36.30
  • RYTM N/A
  • Revenue Growth
  • OLLI 10.14
  • RYTM 54.92
  • 52 Week Low
  • OLLI $94.15
  • RYTM $45.91
  • 52 Week High
  • OLLI $141.74
  • RYTM $116.00
  • Technical
  • Relative Strength Index (RSI)
  • OLLI 51.66
  • RYTM 59.06
  • Support Level
  • OLLI $118.34
  • RYTM $104.42
  • Resistance Level
  • OLLI $126.32
  • RYTM $109.88
  • Average True Range (ATR)
  • OLLI 3.86
  • RYTM 4.43
  • MACD
  • OLLI 0.28
  • RYTM 0.95
  • Stochastic Oscillator
  • OLLI 54.81
  • RYTM 94.31

About OLLI Ollie's Bargain Outlet Holdings Inc.

Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: